Is the use of colloids (fluid resuscitation fluids), specifically albumin, indicated in a patient showing the first symptoms of dengue shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colloid Use in Early Dengue Shock: Not Recommended as First-Line

Crystalloid solutions (isotonic saline or Ringer's lactate) should be used as the initial fluid of choice for dengue shock syndrome, with colloids reserved only for severe shock (pulse pressure <10 mmHg) or crystalloid-refractory cases. 1, 2

Initial Fluid Resuscitation Strategy

Start with crystalloid boluses of 20 mL/kg over 5-10 minutes and reassess immediately. 1, 2 This approach has demonstrated near 100% survival in pediatric dengue shock when applied promptly, regardless of fluid composition used. 3

Why Crystalloids First?

  • Isotonic crystalloids (normal saline or Ringer's lactate) are the evidence-based first-line choice for dengue shock syndrome. 1, 2
  • Multiple randomized controlled trials in dengue-specific populations show that crystalloids achieve similar mortality outcomes to colloids in moderate dengue shock (WHO stage III). 4
  • The largest comparative trial (383 children with moderate dengue shock) found no significant difference in rescue colloid requirements between Ringer's lactate and colloid solutions (relative risk 1.08,95% CI 0.78-1.47, P=0.65). 4
  • Crystalloids are significantly more cost-effective: isotonic saline costs approximately 1.5 Euro per liter versus 25-140 Euro for colloid solutions. 1

When to Consider Colloids

Colloids should only be considered in two specific scenarios:

Severe Dengue Shock

  • Use colloids when pulse pressure is <10 mmHg, indicating severe shock with profound vascular collapse. 1, 2
  • In severe dengue shock (WHO stage IV), colloids provide more rapid normalization of hematocrit and restoration of cardiac index compared to crystalloids. 5

Crystalloid-Refractory Shock

  • Consider colloids when patients fail to respond to initial crystalloid resuscitation with persistent shock despite adequate volume administration. 1, 6
  • Early albumin administration for crystalloid-refractory shock has shown improved outcomes, including decreased positive fluid balance and reduced complications. 6

Choice of Colloid When Indicated

If colloids are necessary, albumin or hydroxyethyl starch are preferred over dextran:

  • Albumin (5%) demonstrates superior control of vascular integrity with lower hemoconcentration, higher platelet counts, and reduced proteinuria compared to crystalloids in hospitalized DHF patients. 7
  • Hydroxyethyl starch (6% HES 130/0.4) may be preferable to dextran 70 due to fewer adverse reactions, despite similar efficacy in severe shock. 4
  • Dextran 70, while providing rapid hematocrit normalization, causes significantly more adverse reactions than starch solutions. 4
  • Avoid hydroxyethyl starches in septic shock contexts, as they increase mortality and renal replacement therapy requirements. 3

Critical Monitoring After Fluid Administration

Reassess immediately after each bolus for:

  • Hemodynamic improvement (pulse pressure, blood pressure, heart rate). 8, 1
  • Signs of adequate tissue perfusion (capillary refill time, skin temperature, mental status, urine output). 1
  • Signs of fluid overload (new onset rales, increased work of breathing, hepatomegaly). 3

Continue fluid boluses only as long as hemodynamic parameters improve. 8 Stop when perfusion normalizes or fluid overload develops. 8

Common Pitfalls to Avoid

  • Do not delay fluid resuscitation while awaiting colloid availability - start with crystalloids immediately. 8, 2
  • Do not use colloids as first-line therapy in moderate dengue shock - this increases costs without mortality benefit. 4
  • Avoid excessive fluid administration in patients without shock, as this leads to fluid overload and respiratory complications. 1
  • Do not fail to recognize the critical phase (days 3-7 of illness) when plasma leakage rapidly progresses to shock. 1
  • Monitor for symptomatic abdominal compartment syndrome in patients requiring large-volume resuscitation, as this complication significantly increases mortality. 6

Subsequent Management

If shock persists despite adequate fluid resuscitation:

  • Consider vasopressor support (dopamine or norepinephrine) targeting MAP ≥65 mmHg. 3, 2
  • Implement proactive fluid removal strategies (diuretics or dialysis) if oliguria develops after aggressive resuscitation, as this approach improves outcomes. 3
  • Patients with >10% fluid overload requiring continuous renal replacement therapy have worse outcomes than those treated earlier. 3

References

Guideline

Fluid Management in Pediatric Dengue

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Research

Targeted Interventions in Critically Ill Children with Severe Dengue.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2018

Guideline

Management of Undifferentiated Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.